Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole in Invasive Fungal Infections
NCT00177749Phase 4Terminated
- Sponsor
- University of Pittsburgh
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of posaconazole in invasive fungal infection (IFI), sponsored by University of Pittsburgh. Primary endpoint: Global response (microbiological and clinical). Started Aug 2004; status: terminated.
02
Drugs
posaconazole
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT00177749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00177749.